App-Quantinova.ai

The modulatory effects of Nrf2 activators in a pulmonary arterial hypertension model

Jian Li - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Pulmonary arterial hypertension

endothelin-1

Endotyping bronchiectasis through multi-omic profiling

Holly Rachael Keir - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Dysbiosis

Interferon Gamma

Targeting histone modifications: H3K27 acetylation regulates the expression of genes involved in key processes of uterine leiomyoma pathogenesis

M C Carbajo-García - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Uterine fibroids

Vorinostat

Characterization of the gene expression profile of breast cancer tumours in patients undergoing ovarian stimulation for fertility preservation purposes

M.J Soriano - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Alora

Letrozole co-treatment during ovarian stimulation in antagonist cycles augments follicle growth and exerts pronounced effects on endocrinology: a randomized controlled trial

L.L.C Poulsen - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Letrozole

SPIRIT long-term extension study: two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain

C Becker - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

Norethisterone acetate

Progesterone luteal-phase support during IUI cycle should be added depending on women age and/or on previous mid-luteal progesterone assessment to promote live births

C.H Petrovic - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Infertility

clomiphene

Methotrexate versus expectant management for treatment of tubal ectopic pregnancy: an individual participant data meta-analysis (IPD-MA

A Solangon - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

Methotrexate

Immune deficiency and endometrial dyshomeostasis in recurrent miscarriages

C.S Kong - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Spontaneous abortion

TIMP-3 secretion inducer

Lower expression of AHCY is associated with increased miscarriage risk

S Harden - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

Ademetionine

Controlled ovarian stimulation (COS protocols for assisted reproduction: a Cochrane systematic review and network meta-analysis

P Melo - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Ovarian hyperstimulation syndrome

N/A

Small extracellular vesicle (sEV protein cargo as potential biomarker for endometriosis

H Nazri - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Endometriosis

N/A

Small extracellular vesicles (sEV in peritoneal fluid and peripheral blood as biomarkers of endometriosis

J Farley - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Endometriosis

N/A

Childhood exposure to high-fat diets changes sperm small RNA content up to two unexposed generations of mice

L Crisóstomo - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Metabolic syndrome

N/A

ESHRE good practice recommendations on chromosomal mosaicism

M De Rycke - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

Surgical and pregnancy outcomes following hysteroscopic adhesiolysis using bipolar electrosurgery in Asherman syndrome: a cohort study

Y AlEbrahim - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Spontaneous abortion

Hyaluronic acid

The Cyprus women’s health research (COHERE initiative: estimating the prevalence, symptomatology, associated risk factors and economic burden of endometriosis in an Eastern Mediterranean population

B Swift - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Vitamin D deficiency

N/A

The VALUE study: a qualitative semi-structured interview study of add-on use by patients, clinicians, and embryologists in the UK and Australia

S Armstrong - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Cross-border reproductive care from France: an original digital survey to measure this phenomenon

V Rozée - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Patients’ willingness and preferences about being counselled for the possibility of fertility treatment being unsuccessful

M Sousa Leite - European Society for Human Reproduction and Embryology (ESHRE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Filters

45280 Abstracts